# Scion Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scion-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Medford, US
- Total disclosed funding: $22M
- Latest round: Series B (Jul 22, 2002)
- Investors on record: 8

## About

Scion Pharmaceuticals, Inc. is based in the US and operates as a pharmaceutical company which engaged in the discovery of novel ion channel modulators.

## Funding rounds

- Series B, Jul 22, 2002, $18M — Oxford Bioscience Partners, EQT Life Sciences, SR One, GeneChem, Gray Ghost Ventures, Lehman Brothers, NeuroVentures, Lancet Capital
- Series A, Nov 1, 2001, $4M — Oxford Bioscience Partners

## Investors

- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series A, Series B
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series B
- SR One (https://capitalatlas.ai/funds/sr-one) — Series B
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series B
- Gray Ghost Ventures (https://capitalatlas.ai/funds/gray-ghost-ventures) — Series B
- Lehman Brothers (https://capitalatlas.ai/funds/lehman-brothers) — Series B
- NeuroVentures (https://capitalatlas.ai/funds/neuroventures) — Series B
- Lancet Capital (https://capitalatlas.ai/funds/lancet-capital) — Series B